Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Evolution, Molecular | 9 | 2014 | 50 | 1.000 |
Why?
|
| Sequence Analysis, DNA | 10 | 2014 | 65 | 0.720 |
Why?
|
| Dendritic Cells | 5 | 2013 | 37 | 0.660 |
Why?
|
| Conserved Sequence | 6 | 2014 | 28 | 0.620 |
Why?
|
| Genome, Human | 6 | 2013 | 57 | 0.590 |
Why?
|
| Genomics | 5 | 2011 | 55 | 0.590 |
Why?
|
| Sequence Analysis, RNA | 3 | 2011 | 40 | 0.570 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 202 | 0.570 |
Why?
|
| Gene Expression Profiling | 4 | 2011 | 112 | 0.510 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 89 | 0.480 |
Why?
|
| RNA, Long Noncoding | 1 | 2014 | 27 | 0.460 |
Why?
|
| Sequence Alignment | 3 | 2011 | 42 | 0.460 |
Why?
|
| Animals | 19 | 2014 | 1946 | 0.460 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 24 | 0.450 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 15 | 0.430 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 41 | 0.390 |
Why?
|
| Mice | 12 | 2014 | 999 | 0.360 |
Why?
|
| Genome | 4 | 2011 | 48 | 0.330 |
Why?
|
| Humans | 18 | 2014 | 3941 | 0.330 |
Why?
|
| Algorithms | 1 | 2009 | 106 | 0.330 |
Why?
|
| RNA, Untranslated | 3 | 2011 | 21 | 0.280 |
Why?
|
| Transcription Factors | 5 | 2012 | 232 | 0.240 |
Why?
|
| Computational Biology | 4 | 2011 | 71 | 0.230 |
Why?
|
| Pluripotent Stem Cells | 2 | 2014 | 15 | 0.210 |
Why?
|
| Chromatin | 4 | 2013 | 74 | 0.210 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 32 | 0.200 |
Why?
|
| RNA | 3 | 2011 | 55 | 0.200 |
Why?
|
| Cell Differentiation | 2 | 2014 | 188 | 0.200 |
Why?
|
| Viruses | 2 | 2011 | 9 | 0.190 |
Why?
|
| Base Sequence | 3 | 2009 | 154 | 0.190 |
Why?
|
| Mammals | 2 | 2011 | 17 | 0.180 |
Why?
|
| Transcription, Genetic | 5 | 2014 | 135 | 0.180 |
Why?
|
| Exons | 4 | 2014 | 27 | 0.180 |
Why?
|
| DNA | 2 | 2012 | 79 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2009 | 2 | 0.160 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 228 | 0.150 |
Why?
|
| Rats | 2 | 2014 | 203 | 0.130 |
Why?
|
| Toll-Like Receptors | 2 | 2011 | 30 | 0.120 |
Why?
|
| Oropharynx | 1 | 2014 | 2 | 0.120 |
Why?
|
| Cattle | 1 | 2014 | 20 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2014 | 24 | 0.120 |
Why?
|
| Viral Matrix Proteins | 1 | 2014 | 6 | 0.120 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2014 | 6 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2014 | 9 | 0.120 |
Why?
|
| Endonucleases | 1 | 2014 | 13 | 0.120 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 26 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2014 | 21 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2011 | 40 | 0.120 |
Why?
|
| Genetic Variation | 1 | 2014 | 65 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 60 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 51 | 0.110 |
Why?
|
| DNA, Intergenic | 2 | 2010 | 7 | 0.110 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 44 | 0.110 |
Why?
|
| CRISPR-Cas Systems | 1 | 2014 | 61 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2008 | 87 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2011 | 159 | 0.110 |
Why?
|
| Synteny | 6 | 2009 | 9 | 0.110 |
Why?
|
| Histones | 1 | 2013 | 42 | 0.110 |
Why?
|
| Models, Genetic | 2 | 2010 | 32 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 37 | 0.110 |
Why?
|
| Haplotypes | 3 | 2009 | 23 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 41 | 0.100 |
Why?
|
| Melanoma | 1 | 2013 | 45 | 0.100 |
Why?
|
| Cell Line | 2 | 2010 | 237 | 0.100 |
Why?
|
| Phylogeny | 4 | 2014 | 43 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2013 | 289 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 38 | 0.090 |
Why?
|
| Female | 6 | 2013 | 1930 | 0.090 |
Why?
|
| Horses | 1 | 2009 | 3 | 0.090 |
Why?
|
| Dogs | 2 | 2009 | 42 | 0.090 |
Why?
|
| Chromosomes, Mammalian | 1 | 2009 | 9 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2011 | 314 | 0.090 |
Why?
|
| Bacteria | 1 | 2009 | 20 | 0.090 |
Why?
|
| Gene Duplication | 2 | 2006 | 9 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2009 | 51 | 0.080 |
Why?
|
| Inflammation | 1 | 2009 | 75 | 0.080 |
Why?
|
| Software | 1 | 2009 | 64 | 0.080 |
Why?
|
| Opossums | 1 | 2007 | 3 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 2 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2005 | 1 | 0.070 |
Why?
|
| Genes | 3 | 2009 | 21 | 0.060 |
Why?
|
| Cell Lineage | 2 | 2014 | 37 | 0.050 |
Why?
|
| Embryonic Stem Cells | 2 | 2014 | 28 | 0.050 |
Why?
|
| Lipopolysaccharides | 2 | 2011 | 65 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 218 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 92 | 0.040 |
Why?
|
| Base Composition | 2 | 2007 | 7 | 0.040 |
Why?
|
| Short Interspersed Nucleotide Elements | 2 | 2006 | 3 | 0.030 |
Why?
|
| Multigene Family | 2 | 2006 | 9 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 4 | 0.030 |
Why?
|
| SOXF Transcription Factors | 1 | 2014 | 6 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 37 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2014 | 35 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 186 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 108 | 0.030 |
Why?
|
| Time Factors | 1 | 2014 | 206 | 0.030 |
Why?
|
| Semiconductors | 1 | 2013 | 2 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 134 | 0.030 |
Why?
|
| Young Adult | 1 | 2014 | 254 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2011 | 7 | 0.030 |
Why?
|
| Interferons | 1 | 2011 | 4 | 0.030 |
Why?
|
| Health | 1 | 2011 | 5 | 0.030 |
Why?
|
| Disease | 1 | 2011 | 4 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2011 | 14 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2011 | 19 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 33 | 0.020 |
Why?
|
| Biotinylation | 1 | 2011 | 2 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2011 | 7 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 20 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 42 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 177 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 119 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 1 | 0.020 |
Why?
|
| Male | 2 | 2006 | 1724 | 0.020 |
Why?
|
| Gene Library | 1 | 2010 | 10 | 0.020 |
Why?
|
| Centromere | 1 | 2009 | 1 | 0.020 |
Why?
|
| Animals, Domestic | 1 | 2009 | 2 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2009 | 10 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2009 | 12 | 0.020 |
Why?
|
| Apoptosis | 1 | 2010 | 110 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 39 | 0.020 |
Why?
|
| Poly I-C | 1 | 2009 | 6 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2009 | 2 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2009 | 12 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 8 | 0.020 |
Why?
|
| Polycomb-Group Proteins | 1 | 2009 | 2 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 18 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 31 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 42 | 0.020 |
Why?
|
| Diploidy | 1 | 2008 | 3 | 0.020 |
Why?
|
| Haploidy | 1 | 2008 | 3 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 8 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 41 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 88 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2007 | 19 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2007 | 22 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 48 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2006 | 4 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2006 | 31 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 20 | 0.020 |
Why?
|
| Defensins | 1 | 2006 | 1 | 0.020 |
Why?
|
| DNA, Satellite | 1 | 2006 | 3 | 0.020 |
Why?
|
| Contig Mapping | 1 | 2006 | 2 | 0.020 |
Why?
|
| Euchromatin | 1 | 2006 | 4 | 0.020 |
Why?
|
| Hybridization, Genetic | 1 | 2005 | 2 | 0.020 |
Why?
|
| Dog Diseases | 1 | 2005 | 8 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2005 | 21 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 7 | 0.020 |
Why?
|
| Introns | 1 | 2005 | 16 | 0.020 |
Why?
|
| CpG Islands | 1 | 2005 | 16 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2005 | 9 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2006 | 61 | 0.020 |
Why?
|